Takeda staged a French outsider into the CEO seat, then sequenced his successor

Takeda, founded in 1781, had only just broken two centuries of family and insider presidents when the board went further: in April 2014 it hired Christophe Weber, a French GSK vaccines chief with experience in nine countries, as chief operating officer. Two months later he was president and representative director; in April 2015 he became the 234-year-old company's first non-Japanese CEO.

The staged entry let a foreign outsider learn the company — and the company learn him — before he held the title. Weber spent a decade globalising: consolidating R&D across Japan and the US, diversifying the leadership team to nine nationalities, and shifting the workforce from 90% Japan-based in 2008 to 70% outside Japan by 2016. He also led the $62 billion Shire takeover that made Takeda a top-10 global drugmaker.

His exit was as planned as his entry. In January 2025 Takeda announced Weber would retire in June 2026 and that Julie Kim — who had arrived via the Shire deal and risen to president of the US business — would succeed him, becoming one of the few women to run a global top-tier drugmaker.

Within a decade Takeda flipped from 90% of staff in Japan to 70% outside, and its CEO relay ended with US head Julie Kim named 17 months before taking over.

A Japan-centric company needed a global operator; hiring one directly as CEO was judged too abrupt, so he entered as COO.

The board pre-committed — president in two months, CEO in a year — giving the outsider a mandate and the organisation a timetable.

Weber's decade proved the model, so the next handover could be announced 17 months early instead of improvised.

Kim came through the Shire acquisition, making the successor a symbol of the globalised company Weber built.

Radical CEO appointments land better in stages: bring the outsider in as COO, let him earn the top job, then publish the next succession long before it happens.

Kim took over in June 2026 with a full year of published transition behind her. Takeda's three-step sequence — insider to first outsider (2003), outsider to first non-Japanese CEO (2015), non-Japanese CEO to a successor grown inside the acquired global business (2026) — is now a standard reference for globalising a Japanese corporate leadership line.